Guidance on nitrosamine impurities in medications.: H164-327/2023E-PDF

"Evaluating and managing the risks of N-nitrosamine impurities in human pharmaceutical, biological and radiopharmaceutical products"--Cover.

Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.921323&sl=0

Publication information
Department/Agency Canada. Health Canada, issuing body.
Title Guidance on nitrosamine impurities in medications.
Publication type Monograph
Language [English]
Other language editions [French]
Later edition Guidance on nitrosamine impurities in medications. July 24, 2023
Earlier edition Guidance on nitrosamine impurities in medications. September 1, 2022
Format Electronic
Electronic document
Note(s) Cover title.
"Date adopted: April 17, 2023. Effective date: April 17, 2023."
Issued also in French under title: Lignes directrices sur les impuretés de nitrosamine dans les médicaments.
Includes bibliographical references.
Publishing information Ottawa, ON : Health Canada = Santé Canada, 2023.
©2023
Description 1 online resource (iii, 25 pages)
ISBN 9780660482057
Catalogue number
  • H164-327/2023E-PDF
Departmental catalogue number 230024
Subject terms Nitrosoamines -- Risk assessment -- Canada.
Drugs -- Risk assessment -- Canada.
Biologicals -- Risk assessment -- Canada.
Radiopharmaceuticals -- Risk assessment -- Canada.
Pharmaceutical policy -- Canada.
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.
Date modified: